Fingerprint
Dive into the research topics of 'Results of TRIO-14, a phase II, multicenter, randomized, placebo-controlled trial of carboplatin-paclitaxel versus carboplatin-paclitaxel-ganitumab in newly diagnosed epithelial ovarian cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically